NATURE’S SUNSHINE PRODUCTS, INC. Stock-Based Compensation
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Stock-Based Compensation of $3.63 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-06
- NATURE’S SUNSHINE PRODUCTS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $1.99M, a 21.55% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $1.64M, a 26.08% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $1.56M, a 28.89% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $1.28M, a 35.26% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $5.78M, a 20.72% increase from fiscal 2024.
- NATURE’S SUNSHINE PRODUCTS, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $4.79M, a 2.15% decline from fiscal 2023.
- NATURE’S SUNSHINE PRODUCTS, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $4.89M, a 68.67% increase from fiscal 2022.
- NATURE’S SUNSHINE PRODUCTS, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $2.90M, a 22.25% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $3.63M 10-Q · filed 2026-08-06 | $5.19M derived: sum of 3 quarters · filed 2026-08-06 | $6.47M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.64M 10-Q · filed 2026-05-07 | $3.20M derived: sum of 2 quarters · filed 2026-05-07 | $4.48M derived: sum of 3 quarters · filed 2026-05-07 | $6.12M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $2.84M derived: sum of 2 quarters · filed 2026-03-10 | $4.48M derived: sum of 3 quarters · filed 2026-08-06 | $5.78M 10-K · filed 2026-03-10 |
| 2025-09-30 | $1.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.92M derived: sum of 2 quarters · filed 2026-08-06 | $4.22M 10-Q · filed 2025-11-06 | $5.43M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.94M 10-Q · filed 2026-08-06 | $4.15M derived: sum of 3 quarters · filed 2026-08-06 | $5.10M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.30M 10-Q · filed 2026-05-07 | $2.51M derived: sum of 2 quarters · filed 2026-05-07 | $3.46M derived: sum of 3 quarters · filed 2026-05-07 | $4.72M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $2.16M derived: sum of 2 quarters · filed 2026-03-10 | $3.42M derived: sum of 3 quarters · filed 2026-03-10 | $4.79M 10-K · filed 2026-03-10 |
| 2024-09-30 | $950.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.21M derived: sum of 2 quarters · filed 2025-11-06 | $3.58M 10-Q · filed 2025-11-06 | $4.68M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $1.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $2.63M 10-Q · filed 2025-07-31 | $3.73M derived: sum of 3 quarters · filed 2025-07-31 | $5.03M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-03-31 | $1.37M 10-Q · filed 2025-05-06 | $2.47M derived: sum of 2 quarters · filed 2025-05-06 | $3.77M derived: sum of 3 quarters · filed 2025-05-06 | $5.20M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $2.40M derived: sum of 2 quarters · filed 2025-03-11 | $3.83M derived: sum of 3 quarters · filed 2025-03-11 | $4.89M 10-K · filed 2025-03-11 |
| 2023-09-30 | $1.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $2.73M derived: sum of 2 quarters · filed 2024-11-07 | $3.79M 10-Q · filed 2024-11-07 | $4.76M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $1.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $2.50M 10-Q · filed 2024-08-08 | $3.46M derived: sum of 3 quarters · filed 2024-08-08 | $4.05M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $1.06M 10-Q · filed 2024-05-07 | $2.02M derived: sum of 2 quarters · filed 2024-05-07 | $2.62M derived: sum of 3 quarters · filed 2024-05-07 | $3.16M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $967.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $1.56M derived: sum of 2 quarters · filed 2024-03-12 | $2.10M derived: sum of 3 quarters · filed 2024-03-12 | $2.90M 10-K · filed 2024-03-12 |
| 2022-09-30 | $593.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $1.13M derived: sum of 2 quarters · filed 2023-11-07 | $1.93M 10-Q · filed 2023-11-07 | $2.71M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $540.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $1.34M 10-Q · filed 2023-08-09 | $2.12M derived: sum of 3 quarters · filed 2023-08-09 | $3.00M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $801.00K 10-Q · filed 2023-05-09 | $1.57M derived: sum of 2 quarters · filed 2023-05-09 | $2.46M derived: sum of 3 quarters · filed 2023-05-09 | $3.53M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $774.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $1.66M derived: sum of 2 quarters · filed 2023-03-16 | $2.73M derived: sum of 3 quarters · filed 2023-03-16 | $3.73M 10-K · filed 2023-03-16 |
| 2021-09-30 | $886.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $1.95M derived: sum of 2 quarters · filed 2022-11-03 | $2.96M 10-Q · filed 2022-11-03 | $4.60M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $2.07M 10-Q · filed 2022-08-09 | $3.72M derived: sum of 3 quarters · filed 2022-08-09 | $4.73M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $1.00M 10-Q · filed 2022-05-05 | $2.65M derived: sum of 2 quarters · filed 2022-05-05 | $3.66M derived: sum of 3 quarters · filed 2022-05-05 | $4.40M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $1.65M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $2.66M derived: sum of 2 quarters · filed 2022-03-08 | $3.39M derived: sum of 3 quarters · filed 2022-03-08 | $3.79M 10-K · filed 2022-03-08 |
| 2020-09-30 | $1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $1.75M derived: sum of 2 quarters · filed 2021-11-04 | $2.14M 10-Q · filed 2021-11-04 | $2.73M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $736.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $1.13M 10-Q · filed 2021-08-05 | $1.72M derived: sum of 3 quarters · filed 2021-08-05 | $2.40M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $394.00K 10-Q · filed 2021-05-06 | $985.00K derived: sum of 2 quarters · filed 2021-05-06 | $1.66M derived: sum of 3 quarters · filed 2021-05-06 | $2.28M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $591.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $1.27M derived: sum of 2 quarters · filed 2021-03-10 | $1.89M derived: sum of 3 quarters · filed 2021-03-10 | $2.12M 10-K · filed 2021-03-10 |
| 2019-09-30 | $678.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $1.30M derived: sum of 2 quarters · filed 2020-11-09 | $1.53M 10-Q · filed 2020-11-09 | $2.24M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $621.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $851.00K 10-Q · filed 2020-08-06 | $1.56M derived: sum of 3 quarters · filed 2020-08-06 | $1.90M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $230.00K 10-Q · filed 2020-05-11 | $942.00K derived: sum of 2 quarters · filed 2020-05-11 | $1.28M derived: sum of 3 quarters · filed 2020-05-11 | $1.86M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $712.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $1.05M derived: sum of 2 quarters · filed 2020-03-11 | $1.63M derived: sum of 3 quarters · filed 2020-03-11 | $2.17M 10-K · filed 2020-03-11 |
| 2018-09-30 | $334.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $915.00K derived: sum of 2 quarters · filed 2019-11-07 | $1.46M 10-Q · filed 2019-11-07 | $1.77M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $581.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $1.12M 10-Q · filed 2019-08-09 | $1.44M derived: sum of 3 quarters · filed 2019-08-09 | $1.58M derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | $543.00K 10-Q · filed 2019-05-09 | $857.00K derived: sum of 2 quarters · filed 2019-05-09 | $999.00K derived: sum of 3 quarters · filed 2019-05-09 | $1.98M derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | $314.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | $456.00K derived: sum of 2 quarters · filed 2019-03-08 | $1.44M derived: sum of 3 quarters · filed 2019-03-08 | $2.22M 10-K · filed 2019-03-08 |
| 2017-09-30 | $142.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $1.13M derived: sum of 2 quarters · filed 2018-11-08 | $1.90M 10-Q · filed 2018-11-08 | $2.71M derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-06-30 | $984.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $1.76M 10-Q · filed 2018-08-08 | $2.57M derived: sum of 3 quarters · filed 2019-03-08 | $3.39M derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-03-31 | $778.00K 10-Q · filed 2018-05-10 | $1.58M derived: sum of 2 quarters · filed 2019-03-08 | $2.41M derived: sum of 3 quarters · filed 2019-03-08 | $3.11M derived: sum of 4 quarters · filed 2019-03-08 |
| 2016-12-31 | $805.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | $1.63M derived: sum of 2 quarters · filed 2019-03-08 | $2.33M derived: sum of 3 quarters · filed 2019-03-08 | $3.22M 10-K · filed 2019-03-08 |
| 2016-09-30 | $826.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $1.53M derived: sum of 2 quarters · filed 2017-11-09 | $2.41M 10-Q · filed 2017-11-09 | $3.62M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-06-30 | $704.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $1.59M 10-Q · filed 2017-08-09 | $2.79M derived: sum of 3 quarters · filed 2018-03-16 | $3.99M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-03-31 | $882.00K 10-Q · filed 2017-05-10 | $2.09M derived: sum of 2 quarters · filed 2018-03-16 | $3.28M derived: sum of 3 quarters · filed 2018-03-16 | $4.03M derived: sum of 4 quarters · filed 2018-03-16 |
| 2015-12-31 | $1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $2.40M derived: sum of 2 quarters · filed 2018-03-16 | $3.15M derived: sum of 3 quarters · filed 2018-03-16 | $4.49M 10-K · filed 2018-03-16 |
| 2015-09-30 | $1.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $1.94M derived: sum of 2 quarters · filed 2016-11-09 | $3.28M 10-Q · filed 2016-11-09 | $4.19M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-06-30 | $746.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $2.08M 10-Q · filed 2016-08-09 | $3.00M derived: sum of 3 quarters · filed 2017-03-14 | $3.95M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-03-31 | $1.34M 10-Q · filed 2016-05-10 | $2.25M derived: sum of 2 quarters · filed 2017-03-14 | $3.21M derived: sum of 3 quarters · filed 2017-03-14 | $4.19M derived: sum of 4 quarters · filed 2017-03-14 |
| 2014-12-31 | $914.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $1.87M derived: sum of 2 quarters · filed 2017-03-14 | $2.85M derived: sum of 3 quarters · filed 2017-03-14 | $3.95M 10-K · filed 2017-03-14 |
| 2014-09-30 | $952.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $1.94M derived: sum of 2 quarters · filed 2015-11-06 | $3.03M 10-Q · filed 2015-11-06 | $3.82M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-06-30 | $988.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $2.08M 10-Q · filed 2015-08-10 | $2.87M derived: sum of 3 quarters · filed 2016-03-14 | $3.54M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-03-31 | $1.09M 10-Q · filed 2015-05-11 | $1.88M derived: sum of 2 quarters · filed 2016-03-14 | $2.55M derived: sum of 3 quarters · filed 2016-03-14 | $3.33M derived: sum of 4 quarters · filed 2016-03-14 |
| 2013-12-31 | $790.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $1.46M derived: sum of 2 quarters · filed 2016-03-14 | $2.24M derived: sum of 3 quarters · filed 2016-03-14 | $3.39M 10-K · filed 2016-03-14 |
| 2013-09-30 | $669.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $1.45M derived: sum of 2 quarters · filed 2014-11-06 | $2.60M 10-Q · filed 2014-11-06 | $3.48M derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-06-30 | $782.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $1.93M 10-Q · filed 2014-08-07 | $2.81M derived: sum of 3 quarters · filed 2015-03-13 | $3.49M derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-03-31 | $1.15M 10-Q · filed 2014-05-08 | $2.02M derived: sum of 2 quarters · filed 2015-03-13 | $2.71M derived: sum of 3 quarters · filed 2015-03-13 | $3.39M derived: sum of 4 quarters · filed 2015-03-13 |
| 2012-12-31 | $877.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $1.56M derived: sum of 2 quarters · filed 2015-03-13 | $2.24M derived: sum of 3 quarters · filed 2015-03-13 | $2.88M 10-K · filed 2015-03-13 |
| 2012-09-30 | $680.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $1.36M derived: sum of 2 quarters · filed 2013-11-08 | $2.00M 10-Q · filed 2013-11-08 | $3.56M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-06-30 | $685.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $1.32M 10-Q · filed 2013-08-09 | $2.88M derived: sum of 3 quarters · filed 2014-03-17 | $3.65M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-03-31 | $636.00K 10-Q · filed 2013-05-09 | $2.20M derived: sum of 2 quarters · filed 2014-03-17 | $2.97M derived: sum of 3 quarters · filed 2014-03-17 | $4.03M derived: sum of 4 quarters · filed 2014-03-17 |
| 2011-12-31 | $1.56M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $2.33M derived: sum of 2 quarters · filed 2014-03-17 | $3.39M derived: sum of 3 quarters · filed 2014-03-17 | $3.48M 10-K · filed 2014-03-17 |
| 2011-09-30 | $773.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $1.83M derived: sum of 2 quarters · filed 2012-11-06 | $1.92M 10-Q · filed 2012-11-06 | $2.03M derived: sum of 4 quarters · filed 2013-03-07 |
| 2011-06-30 | $1.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $1.14M 10-Q · filed 2012-08-03 | $1.26M derived: sum of 3 quarters · filed 2013-03-07 | $1.36M derived: sum of 4 quarters · filed 2013-03-07 |
| 2011-03-31 | $88.00K 10-Q · filed 2012-05-08 | $200.00K derived: sum of 2 quarters · filed 2013-03-07 | $307.00K derived: sum of 3 quarters · filed 2013-03-07 | |
| 2010-12-31 | $112.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | $219.00K derived: sum of 2 quarters · filed 2013-03-07 | $437.00K 10-K · filed 2013-03-07 | |
| 2010-09-30 | $107.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $325.00K 10-Q · filed 2011-11-08 | ||
| 2010-06-30 | $218.00K 10-Q · filed 2011-08-05 | |||
| 2009-12-31 | $478.00K 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |